Diamedica Therapeutics's market cap is currently $282.65M. The company's EPS TTM is $-0.552; its P/E ratio is ―; Diamedica Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -30.00K	$ -25.00K	$ -24.00K	$ -21.00K	$ -21.00K
Operating Income	$ -21.27M	$ -14.00M	$ -13.65M	$ -12.70M	$ -11.59M
EBITDA	$ -19.31M	$ -13.98M	$ -13.62M	$ -12.24M	$ -10.60M
Net Income	$ -19.38M	$ -13.68M	$ -13.59M	$ -12.29M	$ -10.65M
Balance Sheet
Cash & Short-Term Investments	$ 52.90M	$ 33.50M	$ 45.11M	$ 27.51M	$ 7.88M
Total Assets	$ 54.16M	$ 34.40M	$ 45.55M	$ 28.09M	$ 9.05M
Total Debt	$ 400.00K	$ 469.00K	$ 52.00K	$ 118.00K	$ 178.00K
Net Debt	$ -4.14M	$ -4.26M	$ -4.66M	$ -7.29M	$ -3.71M
Total Liabilities	$ 3.10M	$ 2.57M	$ 1.53M	$ 2.08M	$ 1.44M
Stockholders' Equity	$ 51.06M	$ 31.83M	$ 44.02M	$ 26.01M	$ 7.62M
Cash Flow
Free Cash Flow	$ -18.75M	$ -11.59M	$ -12.27M	$ -9.23M	$ -9.10M
Operating Cash Flow	$ -18.73M	$ -11.51M	$ -12.25M	$ -9.19M	$ -9.10M
Investing Cash Flow	$ -18.30M	$ 11.54M	$ -20.54M	$ -16.13M	$ -3.91M
Financing Cash Flow	$ 36.84M	$ -6.00K	$ 30.09K	$ 28.84M	$ 70.00K

Currency in USD

Diamedica Therapeutics Earnings and Revenue History

Income Statement >

Diamedica Therapeutics Debt to Assets

Balance Sheet >

Diamedica Therapeutics Cash Flow

Cash Flow >

Diamedica Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing